Linking genomic reorganization to tumor initiation via the giant cell cycle

Oncogenesis

Volumn 5, Issue 12, 2016, Pages

  Niu, N ^a   Zhang, J ^a   Zhang, N ^a   Mercado Uribe, I ^a   Tao, F ^a   Han, Z ^a   Pathak, S ^a   Multani, A S ^a   Kuang, J ^a   Yao, J ^a   Bast, R C ^a   Sood, A K ^a   Hung, M C ^a,b   Liu, J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; FLUORESCENT UBIQUITINATION CELL CYCLE INDICATOR; GREEN FLUORESCENT PROTEIN; HISTONE H2B; PACLITAXEL; RED FLUORESCENT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL BUDDING; CELL DEATH; CELL FATE; CELL LEVEL; CELL NUCLEUS; CELL SELF-RENEWAL; CELL TRACKING; CHROMOSOME STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DAUGHTER CELL; DNA FRAGMENTATION; ENDOREDUPLICATION; FEMALE; FLUORESCENCE IMAGING; GENOMIC INSTABILITY; GIANT CELL; HUMAN; HUMAN CELL; LIVE CELL IMAGING; MITOSIS; MITOSIS SPINDLE; OVARIAN CANCER CELL LINE; POLYPLOID GIANT CANCER CELL; POLYPLOIDY; PRIORITY JOURNAL; TIME LAPSE IMAGING;

EID: 85012232661     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2016.75     Document Type: Article

References (48)

1. Edgar BA, Zielke N, Gutierrez C. Endocycles: a recurrent evolutionary innovation for post-mitotic cell growth. Nat Rev Mol Cell Biol 2014; 15: 197–210.
2. Fox DT, Duronio RJ. Endoreplication and polyploidy: insights into development and disease. Development 2013; 140: 3–12.
3. Orr-Weaver TL. When bigger is better: the role of polyploidy in organogenesis. Trends Genet 2015; 31: 307–315.
4. Zielke N, Edgar BA, DePamphilis ML. Endoreplication. Cold Spring Harbor Perspect Biol 2013; 5: a012948.
5. Duncan AW, Taylor MH, Hickey RD, Hanlon Newell AE, Lenzi ML, Olson SB et al. The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 2010; 467: 707–710.
6. Zack TI, Schumacher SE, Carter SL, Cherniack AD, Saksena G, Tabak B et al. Pan-cancer patterns of somatic copy number alteration. Nat Genet 2013; 45: 1134–1140.
7. Levan A, Hauschka TS. Endomitotic reduplication mechanisms in ascites tumors of the mouse. J Natl Cancer Inst 1953; 14: 1–43.
8. Barrett MT, Pritchard D, Palanca-Wessels C, Anderson J, Reid BJ, Rabinovitch PS. Molecular phenotype of spontaneously arising 4N (G2-tetraploid) intermediates of neoplastic progression in Barrett's esophagus. Cancer Res 2003; 63: 4211–4217.
9. McCluggage WG, Lyness RW, Atkinson RJ, Dobbs SP, Harley I, McClelland HR et al. Morphological effects of chemotherapy on ovarian carcinoma. J Clin Pathol 2002; 55: 27–31.
10. Fei F, Zhang D, Yang Z, Wang S, Wang X, Wu Z et al. The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer. J Exp Clin Cancer Res 2015; 34: 158.
11. Zhivotovsky B, Kroemer G. Apoptosis and genomic instability. Nat Rev Mol Cell Biol 2004; 5: 752–762.
12. Ganem NJ, Pellman D. Limiting the proliferation of polyploid cells. Cell 2007; 131: 437–440.
13. Vitale I, Galluzzi L, Senovilla L, Criollo A, Jemaa M, Castedo M et al. Illicit survival of cancer cells during polyploidization and depolyploidization. Cell Death Differ 2011; 18: 1403–1413.
14. Ewald JA, Desotelle JA, Wilding G, Jarrard DF. Therapy-induced senescence in cancer. J Natl Cancer Inst 2010; 102: 1536–1546.
15. Wen Q, Goldenson B, Silver SJ, Schenone M, Dancik V, Huang Z et al. Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL. Cell 2012; 150: 575–589.
16. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 2005; 437: 1043–1047.
17. Vitale I, Senovilla L, Jemaa M, Michaud M, Galluzzi L, Kepp O et al. Multipolar mitosis of tetraploid cells: inhibition by p53 and dependency on Mos. EMBO J 2010; 29: 1272–1284.
18. Davoli T, de Lange T. Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells. Cancer Cell 2012; 21: 765–776.
19. Walen KH. Budded karyoplasts from multinucleated fibroblast cells contain centrosomes and change their morphology to mitotic cells. Cell Biol Int 2005; 29: 1057–1065.
20. Erenpreisa JA, Cragg MS, Fringes B, Sharakhov I, Illidge TM. Release of mitotic descendants by giant cells from irradiated Burkitt's lymphoma cell line. Cell Biol Int 2000; 24: 635–648.
21. Erenpreisa J, Ivanov A, Wheatley SP, Kosmacek EA, Ianzini F, Anisimov AP et al. Endopolyploidy in irradiated p53-deficient tumour cell lines: persistence of cell division activity in giant cells expressing Aurora-B kinase. Cell Biol Int 2008; 32: 1044–1056.
22. Puig PE, Guilly MN, Bouchot A, Droin N, Cathelin D, Bouyer F et al. Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy. Cell Biol Int 2008; 32: 1031–1043.
23. Rohnalter V, Roth K, Finkernagel F, Adhikary T, Obert J, Dorzweiler K et al. A multi-stage process including transient polyploidization and EMT precedes the emergence of chemoresistent ovarian carcinoma cells with a dedifferentiated and pro-inflammatory secretory phenotype. Oncotarget 2015; 6: 40005–40025.
24. Sundaram M, Guernsey DL, Rajaraman MM, Rajaraman R. Neosis: a novel type of cell division in cancer. Cancer Biol Ther 2004; 3: 207–218.
25. Zhang S, Mercado-Uribe I, Liu J. Tumor stroma and differentiated cancer cells can be originated directly from polyploid giant cancer cells induced by paclitaxel. Int J Cancer 2013; 134: 508–518.
26. Zhang S, Mercado-Uribe I, Xing Z, Sun B, Kuang J, Liu J. Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene 2014; 33: 116–128.
27. Leikam C, Hufnagel AL, Otto C, Murphy DJ, Muhling B, Kneitz S et al. In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells. Cell Death Dis 2015; 6: e1711.
28. Zheng L, Dai H, Zhou M, Li X, Liu C, Guo Z et al. Polyploid cells rewire DNA damage response networks to overcome replication stress-induced barriers for tumour progression. Nat Commun 2012; 3: 815.
29. Dewhurst SM, McGranahan N, Burrell RA, Rowan AJ, Gronroos E, Endesfelder D et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Disc 2014; 4: 175–185.
30. Weihua Z, Lin Q, Ramoth AJ, Fan D, Fidler IJ. Formation of solid tumors by a single multinucleated cancer cell. Cancer 2011; 117: 4092–4099.
31. Zhang S, Mercado-Uribe I, Liu J. Generation of erythroid cells from fibroblasts and cancer cells in vitro and in vivo. Cancer Lett 2013; 333: 205–212.
32. Zhang S, Mercado-Uribe I, Sood A, Bast RC, Liu J. Coevolution of neoplastic epithelial cells and multilineage stroma via polyploid giant cells during immortalization and transformation of mullerian epithelial cells. Genes Cancer 2016; 7: 60–72.
33. Zasadil LM, Andersen KA, Yeum D, Rocque GB, Wilke LG, Tevaarwerk AJ et al. Cytotoxicity of paclitaxel in breast cancer is due to chromosome missegregation on multipolar spindles. Sci Transl Med 2014; 6: 229ra243.
34. Fine RL, Chen J, Balmaceda C, Bruce JN, Huang M, Desai M et al. Randomized study of paclitaxel and tamoxifen deposition into human brain tumors: implications for the treatment of metastatic brain tumors. Clin Cancer Res 2006; 12: 5770–5776.
35. Sakaue-Sawano A, Kurokawa H, Morimura T, Hanyu A, Hama H, Osawa H et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 2008; 132: 487–498.
36. Horne SD, Chowdhury SK, Heng HH. Stress, genomic adaptation, and the evolutionary trade-off. Front Genet 2014; 5: 92.
37. Meyerson M, Pellman D. Cancer genomes evolve by pulverizing single chromosomes. Cell 2011; 144: 9–10.
38. Zhang CZ, Leibowitz ML, Pellman D. Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements. Genes Dev 2013; 27: 2513–2530.
39. McClintock B. The significance of responses of the genome to challenge. Science 1984; 226: 792–801.
40. Erenpreisa J, Kalejs M, Ianzini F, Kosmacek EA, Mackey MA, Emzinsh D et al. Segregation of genomes in polyploid tumour cells following mitotic catastrophe. Cell Biol Int 2005; 29: 1005–1011.
41. Walen KH. Genetic stability of senescence reverted cells: genome reduction division of polyploidy cells, aneuploidy and neoplasia. Cell Cycle 2008; 7: 1623–1629.
42. Walen KH. Mitosis is not the only distributor of mutated cells: non-mitotic endopolyploid cells produce reproductive genome-reduced cells. Cell Biol Int 2010; 34: 867–872.
43. Rajaraman R, Guernsey DL, Rajaraman MM, Rajaraman SR. Stem cells, senescence, neosis and self-renewal in cancer. Cancer Cell Int 2006; 6: 25.
44. Erenpreisa J, Cragg MS. Cancer: a matter of life cycle? Cell Biol Int 2007; 31: 1507–1510.
45. Erenpreisa J, Cragg MS. Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal. Cancer Cell Int 2013; 13: 92.
46. Erenpreisa J, Cragg MS. MOS, aneuploidy and the ploidy cycle of cancer cells. Oncogene 2010; 29: 5447–5451.
47. Chen S, Stout JR, Dharmaiah S, Yde S, Calvi BR, Walczak CE. Transient endoreplication down-regulates the kinesin-14 HSET and contributes to genomic instability. Mol Biol Cell 2016; 27: 2911–2923.
48. Niu N, Zhang J, Huang T, Sun Y, Chen Z, Yi W et al. IgG expression in human colorectal cancer and its relationship to cancer cell behaviors. PLoS ONE 2012; 7: e47362.